Institutional investors hold a majority ownership of AMGN through the 82.93% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2013, these large investors purchased a net $535.7 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STANDARD LIFE INVESTMENTS LTD. Bought 112.5 Thousand shares of Amgen Inc